LORIS I.V. PRO - SPONGE 2 %
CHLORHEXIDINE GLUCONATE : 2 % ISOPROPYL ALCOHOL : 70 % · DIN 02465213 · LERNAPHARM (LORIS) INC.
Health Canada status: APPROVED
What is LORIS I.V. PRO - SPONGE?
LORIS I.V. PRO - SPONGE 2 % contains CHLORHEXIDINE GLUCONATE : 2 % ISOPROPYL ALCOHOL : 70 %. It is listed in the Health Canada Drug Product Database under DIN 02465213, held by LERNAPHARM (LORIS) INC., supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as approved, status dated 11-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02465213 |
|---|---|
| Brand name | LORIS I.V. PRO - SPONGE |
| Generic / active ingredient | CHLORHEXIDINE GLUCONATE : 2 % ISOPROPYL ALCOHOL : 70 % |
| Manufacturer | LERNAPHARM (LORIS) INC. |
| Strength | 2 % |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D08AC52 CHLORHEXIDINE, COMBINATIONS |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 11-Jul-2018 |
What can be used instead?
Other Canadian products sharing ATC code D08AC52 CHLORHEXIDINE, COMBINATIONS. 12 of 49 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AVAGARD CHG | 61 % | LOTION | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02246888 |
| BAXEDIN 2% - 70% | 70 % | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02251477 |
| CHLORAPREP | 70 % | SOLUTION | BECTON DICKINSON CANADA INC. | MARKETED | DIN 02484374 |
| CHLORAPREP SWABSTICKS | 2 % | SWAB | BECTON DICKINSON CANADA INC. | MARKETED | DIN 02525585 |
| DEXIDIN 0.5 SOLUTION | 70.0 % | LIQUID | LABORATOIRE ATLAS INC | MARKETED | DIN 02240680 |
| SOLUPREP APPLICATOR | 70 % | SOLUTION | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02382113 |
| SOLUPREP QD SWAB | 70 % | SWAB | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02119803 |
| SOLUPREP QD WIPE | 0.5 % | WIPE | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02060019 |
| SOLUPREP SWAB | 2 % | SWAB | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02382040 |
| SOLUPREP WIPE | 70 % | WIPE | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02385708 |
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.